ArticleThe journal of allergy and clinical immunology. Global2025

Effectiveness of dupilumab treatment against refractory eosinophilic chronic rhinosinusitis.

Daiki Nakashima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.